AMRX

Latest SEC Filings & News for AMRX

1 most recent filing and news item mentioning AMRX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/AMRX/news?limit=20"

Pull AMRX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsJul 30, 2026Positive

Amneal Reports Q2 2026 Net Revenue of $796 Million

Amneal Pharmaceuticals reported strong second-quarter performance with net revenue of $796 million and raised its full-year 2026 guidance. The company also announced a successful debt repricing to lower interest costs.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.